Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population

Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population

BACKGROUND/PURPOSE: Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients over 55 years. Currently, the most common therapies for neovascular AMD (nAMD) are intravitreal antiangiogenics. Studies suggest that genetic factors influence on antiangiogenics therapy...

Full description

Bibliographic Details
Main Authors: Francisco Jose Rodriguez, Hernan Andres Rios, María Camila Aguilar, Shirley Margarita Rosenstiehl, Nancy Gelvez, Greizy Lopez, Martha L Tamayo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
angiogenesis inhibitors
hispanic americans
macular degeneration
polymorphism
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=4;spage=243;epage=248;aulast=Rodriguez

Internet

http://www.e-tjo.org/article.asp?issn=2211-5056;year=2019;volume=9;issue=4;spage=243;epage=248;aulast=Rodriguez

Similar Items